ÈËÆÞÖгöÊÓÆµ

Skip to main content
Michael P. Teske
Rating: 4.9 of 5
( out of 641 reviews )

Michael P. Teske, MD

Languages spoken: English
  • Michael P. Teske, MD, is an emeritus clinical professor who specializes in medical and surgical diseases of the retina and vitreous.

    Board Certification

    American Board of Ophthalmology
    National Board of Medical Examiners

    Patient Rating

    Rating: 4.9 out of 5
    4.9 /5
    ( out of 641 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    July 18, 2025
    MORAN EYE CENTER
    Rating: 5 out of 5

    I'm sad that Dr Teske retired, But he deserves to do so!

    July 17, 2025
    MIDVALLEY
    Rating: 4 out of 5

    I did not get treatment from Dr. Teske. I never saw him.

    July 16, 2025
    MORAN EYE CENTER
    Rating: 5 out of 5

    Just terrific

    July 11, 2025
    MIDVALLEY
    Rating: 5 out of 5

    Very pleasant, highly informative, best doc I have ever had.

    July 05, 2025
    MORAN EYE CENTER
    Rating: 5 out of 5

    Congratulation on your well earned retirement!

    July 03, 2025
    MIDVALLEY
    Rating: 5 out of 5

    Simply the best

    June 28, 2025
    MORAN EYE CENTER
    Rating: 5 out of 5

    We have been seeing him for 30 years and heÕs been the best!

    June 27, 2025
    MIDVALLEY
    Rating: 5 out of 5

    Dr. Teske is a very good doctor. He has been professional, knowledgeable and caring about you as the patient.

    June 26, 2025
    MIDVALLEY
    Rating: 5 out of 5

    A very outstanding, kind, knowledgeable retinologist. He listens and explains oneÕs condition and what can be done to cure it or what else can be done to make it better than it is.

  • Michael P. Teske, MD, is an emeritus clinical professor who specializes in medical and surgical diseases of the retina and vitreous.

    Board Certification and Academic Information

    Academic Departments Ophthalmology & Visual Sciences -Professor (Clinical) Emeritus
    Board Certification
    American Board of Ophthalmology
    National Board of Medical Examiners

    Education history

    Fellowship Retina/Vitreous - Wayne State ÈËÆÞÖгöÊÓÆµ, Kresge Eye Institute Fellow
    Residency Ophthalmology - ÈËÆÞÖгöÊÓÆµ of Utah School of Medicine Resident
    Internship Internal Medicine - ÈËÆÞÖгöÊÓÆµ of Utah School of Medicine Intern
    Professional Medical Medicine - ÈËÆÞÖгöÊÓÆµ of California - Los Angeles M.D.
    Undergraduate ÈËÆÞÖгöÊÓÆµ of Notre Dame B.S.

    Selected Publications

    Journal Article

    1. Birch DG, Bernstein PS, Iannacone A, Pennesi ME, Lam BL, Heckenlively J, Csaky K, Hartnett ME, Winthrop KL, Jayasundera T, Hughbanks-Wheaton DK, Warner J, Yang P, Fish GE, Teske MP, Sklaver NK, Erker L, Chegarnov E, Smith T, Wahle A, VanVeldhuisen PC, McCormack J, Lindblad R, Bramer S, Rose S, Zilliox P, Francis PJ, Weleber RG (08/01/2018). Effect of Oral Valproic Acid vs. Placdbo for Vision Loss in Paients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial. JAMA Ophthalmol, 136(8), 849-856.
    2. Birch DG, Bernstein PS, Iannacone A, Pennesi ME, Lam BL, Heckenlively J, Csaky K, Hartnett ME, Winthrop KL, Jayasundera T, Hughbanks-Wheaton DK, Warner J, Yang P, Fish GE, Teske MP, Sklaver NL, Erker L, Chegarnov E, Smith T, Wahle A, VanVeldhuisen PC, McCormack J, Lindblad R, Bramer S, Rose S, Zilliox P, Francis PJ, Weleber RG (2018). Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial. JAMA Ophthalmol, 136(8), 849-856. ()
    3. Bell JE, Shulman JP, Swan RJ, Teske MP, Bernstein PS (2017). Intravitreal Versus Subretinal Tissue Plasminogen Activator Injection for Submacular Hemorrhage. Ophthalmic Surg Lasers Imaging Retina, 48(1), 26-32. ()